Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.FDA grants priority review for Daiichi and Lilly’s anti-clot drug
A priority designation by the FDA sets the PDUFA (Prescription Drug User Fee Act) goal date. The PDUFA goal for priority applications is to have an action provided
A priority designation by the FDA sets the PDUFA (Prescription Drug User Fee Act) goal date. The PDUFA goal for priority applications is to have an action provided
The NPM1 mutation may also be used to monitor AML patients for residual disease during chemotherapy. Stratification of AML patients is also necessary for anti-AML drug clinical trials.
Under the terms of the merger agreement, Radiation Therapy Services shareholders are entitled to receive $32.50 in cash, without interest, for each share of Radiation Therapy Services common
The transaction is subject to customary closing conditions, including clearance by US antitrust authorities. It will become effective as soon as these conditions have been satisfied. All 170
According to Mr. Arnes, the cost-containment measures of the government had adverse impact on the fortunes of the pharmaceutical industry, as it affected the R&D allocations and lowered
According to the report, the latest pricing proposals allow for an increase in premiums to be awarded and, for innovative drugs, the premium range will be increased. Japan’s
Abilify is intended for the treatment of schizophrenia. It is also indicated for the treatment of moderate to severe manic episodes in bipolar I Disorder and for the
The benefits with Pandemrix are that it can mount an appropriate immune response in individuals that are immunologically naive against the mock-up vaccine strain. It is an adjuvanted
Alimta in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell
The active substance of Mycamine is micafungin, an antimycotic for systemic use. The benefits with Mycamine are its clinical and microbiological cure and prophylaxis of Candida infection. The